Delivery Order SPE2DB24D2102-SPE2DB25FJHTE

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,537.06, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of February 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,466.72 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $13,495.17 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $72,783.49, is for the supply of Ozempic 0.25-0.5 mg/dose pens with a delivery date of February 4, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,253.32, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 27, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,599.82, is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has a firm-fixed price pricing type and a completion date of December 5, 2024. This contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,558.56 contract is for the supply of Ozempic 0.25-0.5 mg/dose pens. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that runs through December 2025, under which AmerisourceBergen provides a comprehensive range of pharmaceutical and medical supplies to support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,079.62, is for the supply of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract, valued at $16,717.73, is for the supply of Ozempic 0.25-0.5 mg/dose pens to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has a firm fixed price of $11,772.22 and a period of performance through September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order. The contract is not set aside for any specific business type. This delivery order is part of a larger Indefinite Delivery...
  • SPE2DB24D2102
    Indefinite Delivery Contract
  • SPE2DB24D2102-SPE2DB25FJHTE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,468.07, is for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL). The contract is a firm fixed-price, delivery order type, with a period of performance ending on January 22, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/22/25, 11:14 AM